A Phase III Transition Study of DRL Rituximab to Reference Medicinal Products
Clinical trial NCT04268771 · COMPLETED
Trial details
- NCT number
- NCT04268771
- Sponsor
- Dr. Reddy's Laboratories Limited
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-08
- Primary completion
- 2022-01-26
- Enrollment
- 140
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.